
Mikkel Christensen
@drmikkelc
ID: 2686912247
08-07-2014 12:20:02
270 Tweet
42 Followers
126 Following

This week's unreported clinical trial of the week explains why it is still important that trial results are reported even if the trial itself has been halted: blogs.bmj.com/bmj/2018/09/04… Nick DeVito Ben Goldacre





Via James Packard Love, jamielove.bsky.social Germany + Denmark are trying to soften World Health Assembly statements on getting #alltrials reported e.g. Para 7: keionline.org/wp-content/upl… Note also the German group misrepresent Helsinki which says ALL results reported. Para 36 here: wma.net/policies-post/…


If you need an overview of the more than 20 drug classes in clinical development for T2D, with an outline of their mode of action, efficacy, safety, and current status, dig in! Mikkel Christensen tandfonline.com/eprint/UGR9UFZ…



Today in Hamburg, Sebastian Johansson elegantly presented data indicating potential #ageism in type 2 diabetes. With increasing age we observed more use of SUs and less use of SGLT-2Is and GLP-1RAs when corrected for all available confounders. #EASD2023 Klinisk Farmakologisk Afdeling @bfhosp


Among those hospitalized for COVID-19 in the capital region of Denmark, patients with #T2D did not have a higher risk of death and ICU admission when adjusting for confounders. Thanks to Dr. Vivian Kliim-Hansen leading this project 🤩 Open acces in DOM: …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…




Polypharmacy in T2D is rising. Vital for managing comorbidities and curbing CVD, awareness of its risks, such as drug interactions, adverse effects and challenges of over/underprescribing is crucial. ADA Professional Publications Read Here➡️doi.org/10.2337/dc24-0…





